VJDementia Podcast

vjdementia
  • 0.0 (0)
  • MEDICINE

The Video Journal of Dementia (VJDementia) podcast covers the latest dementia news from international experts - from Alzheimer’s disease, vascular dementia, to Lewy body dementia and more. Made for healthcare professionals and researchers, we are a global, independent, open-access platform. Listen to the latest news, including cutting-edge trial updates, controversies and opinions. If you enjoy the podcast, please leave us a rating and review! For more news visit www.vjdementia.com

Episodes

  1. FEB 19

    Beyond amyloid and tau: novel strategies being explored for the treatment of dementia

    This podcast episode explores emerging therapeutic strategies for dementia that extend beyond traditional amyloid- and tau-targeted approaches. Hussein Yassine, MD, Keck School of Medicine of USC, Los Angeles, CA, discusses APOE-directed therapies, followed by Pamela Maher, PhD, Salk Institute for Biological Studies, San Diego, CA, who speaks about the development and Phase I (NCT05318040) findings on CMS121, a fisetin derivative. Sharon Sha, MD, MS, Stanford University Medical Center, Stanford, CA, discusses PDE5 inhibitors, including Phase II findings and the ongoing Phase III POLARIS-AD (NCT05531526) study evaluating mirodenafil. Finally, James Galvin, MD, MPH, Miller School of Medicine, Miami, FL, shares findings from a Phase II trial (NCT05869669) investigating neflamapimod in dementia with Lewy bodies.

    19 min

  2. 02/17/2025

    Practical considerations when using anti-amyloid antibodies for the treatment of Alzheimer’s disease

    Anti-amyloid antibodies are the first disease-modifying therapies for Alzheimer’s disease (AD), with two agents—lecanemab and donanemab—now fully approved by the... The post Practical considerations when using anti-amyloid antibodies for the treatment of Alzheimer’s disease appeared first on VJDementia.

    20 min

  3. 07/31/2024

    Exploring plasma p-tau217: a game-changer in Alzheimer’s trials

    In this episode, we dive into the latest advancements in Alzheimer’s disease (AD) biomarkers, focusing on the diagnostic and predictive... The post Exploring plasma p-tau217: a game-changer in Alzheimer’s trials appeared first on VJDementia.

    19 min

  4. 12/20/2023

    Eyes on Alzheimer’s: the promise of the retina in research and healthcare

    The retina is often considered an extension of the brain, as they share many functional and structural similarities. Retinal changes... The post Eyes on Alzheimer’s: the promise of the retina in research and healthcare appeared first on VJDementia.

    18 min

  5. 04/14/2023

    Exciting developments in microglia research in Alzheimer’s disease

    Genetic studies have shown that the vast majority of risk genes for Alzheimer’s Disease (AD) are highly, or even preferentially,... The post Exciting developments in microglia research in Alzheimer’s disease appeared first on VJDementia.

    22 min

  6. 03/15/2023

    Expert perspectives on lecanemab

    On January 6, 2023, the US Food and Drug Administration (FDA) approved lecanemab for the treatment of Alzheimer’s disease (AD),... The post Expert perspectives on lecanemab appeared first on VJDementia.

    23 min

  7. 12/05/2022

    Nutrition and cognitive decline

    Cognitive decline caused by dementia is one of the leading causes of disability and dependency for older adults globally, and... The post Nutrition and cognitive decline appeared first on VJDementia.

    23 min

  8. 10/31/2022

    Novel markers for Alzheimer’s disease monitoring and prognostication

    Our current podcast series is focused on Alzheimer’s disease biomarkers. Hundreds of studies have emerged in recent years that have... The post Novel markers for Alzheimer’s disease monitoring and prognostication appeared first on VJDementia.

    15 min

  9. 10/07/2022

    Early biomarkers for Alzheimer’s disease

    Blood biomarkers are taking off in the Alzheimer’s disease field, showing promise for diagnosis, prognostication, and treatment monitoring. As more... The post Early biomarkers for Alzheimer’s disease appeared first on VJDementia.

    20 min

  10. 09/06/2022

    Alzheimer’s disease blood tests? Bringing plasma biomarkers into clinical practice

    Blood biomarkers are taking off in the Alzheimer’s disease field, showing promise for diagnosis, prognostication, and treatment monitoring. Current diagnostic... The post Alzheimer’s disease blood tests? Bringing plasma biomarkers into clinical practice appeared first on VJDementia.

    21 min

  11. 07/29/2022

    Immunotherapy for Alzheimer’s disease: targeting β-amyloid and tau

    The complexity of Alzheimer’s disease (AD) pathogenesis has led to difficulties understanding the disease and, therefore, impacted the development of... The post Immunotherapy for Alzheimer’s disease: targeting β-amyloid and tau appeared first on VJDementia.

    13 min
  • 11 Episodes

About

The Video Journal of Dementia (VJDementia) podcast covers the latest dementia news from international experts - from Alzheimer’s disease, vascular dementia, to Lewy body dementia and more. Made for healthcare professionals and researchers, we are a global, independent, open-access platform. Listen to the latest news, including cutting-edge trial updates, controversies and opinions. If you enjoy the podcast, please leave us a rating and review! For more news visit www.vjdementia.com

Information

  • Creator
    vjdementia
  • Years Active
    2022 - 2026
  • Episodes
    11
  • Rating
    Clean
  • Copyright
    © Copyright 2022 All rights reserved.
  • Show Website
    VJDementia Podcast

You Might Also Like